ISF LLC
15Patents
2Active
15Granted
33Portfolio score
Filing activity: Mar 29, 1985 → Aug 18, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5122376A | Calcitonin gene related peptide | Human Necessities | 20 | Expired |
| US5183802A | Pharmaceutical compositions for intranasal administration of calcitonin | Human Necessities | 11 | Expired |
| US5053422A | Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives | Human Necessities | 10 | Expired |
| US5130319A | Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines | Human Necessities | 4 | Expired |
| US4757142A | Process for preparing 6-amino-3-hydrazinopyridazine derivatives | Chemistry; Metallurgy | 3 | Expired |
| US4629797A | Process for the preparation of pyrrolidone derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9346830B2 | Method for producing amino acid chelate compounds, amino acid chelate compounds and use of amino acid chelate compounds | Emerging Cross-Sectional Technologies | 2 | Active |
| US4788300A | Substituted butanamido acetate compounds for the preparation of pyrrolidone derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4797496A | Process for the preparation of pyrrolidone derivatives | Chemistry; Metallurgy | 2 | Expired |
| US4824861A | Pyrrolidone derivatives and memory enhancement use thereof | Human Necessities | 1 | Expired |
| US5200406A | Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines | Human Necessities | 1 | Expired |
| US4873328A | Process for preparing alkoxyalkylidenehydrazinopyridazine derivatives | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4868313A | A process for making pyrrolidone derivatives | Human Necessities | 1 | Expired |
| US11272727B2 | Method for extracting sea cucumber saponin-containing extract and method for maintaining constant content thereof | Human Necessities | 0 | Active |
| US5082939A | Pyridazine derivatives | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.